← Leaderboards
Jaime R Merchan
University Of Miami School Of Medicine
$2,129,967
Attributed
$2,129,967
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $361.3K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,129,967 · 2
By mechanism
R01$1,677,868 · 1
R21$452,099 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Glen N. Barber$22,145,694
- Vinata B Lokeshwar$10,655,590
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResponseDoseMolecularBaseAngiogenesis InhibitorsRenal CarcinomaTumorSafetyBreast Cancer ModelBlood VesselsBiological ProductsAreaCancer ModelEnvironmentExtracellular MatrixFibroblastsClinicClinical TrialsBiodistributionColon CarcinomaAffectAnticancer ResearchAdvanced Malignant Neoplasm
Grant awards (9)
Tumor and Stromal Targeting by Oncolytic Viruses$317,475
R01 · FY2015 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$17,175
R01 · FY2015 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$332,201
R01 · FY2014 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$29,140
R01 · FY2014 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$321,927
R01 · FY2013 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$342,475
R01 · FY2012 · CA · contact PI
Tumor and Stromal Targeting by Oncolytic Viruses$317,475
R01 · FY2011 · CA · contact PI
Biomarkers for VEGF and mTOR Blockade in Advanced Renal Cancer$223,001
R21 · FY2007 · CA · contact PI
Biomarkers for VEGF and mTOR Blockade in Advanced Renal Cancer$229,098
R21 · FY2006 · CA · contact PI